688331.SS SHH
RemeGen Co. Ltd. Class A
1W: -6.2%
1M: -3.6%
3M: -16.4%
YTD: +10.0%
1Y: +87.4%
3Y: +78.5%
¥117.34 ($17.50)
+0.67 (+0.57%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$3.3B
+89.4% ▲
Gross Profit
$3.3B
+137.3% ▲
Operating Income
$721M
+149.6% ▲
Net Income
$709M
+148.3% ▲
EPS (Diluted)
$1.29
+147.3% ▲
EBITDA
$940M
+180.7% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $1.4B | $772M | $1.1B | $1.7B | $3.3B |
| YoY Growth | +293264.9% | -45.8% | +40.3% | +58.5% | +89.4% |
| Cost of Revenue | $67M | $272M | $257M | $347M | $0 |
| Gross Profit | $1.4B | $500M | $826M | $1.4B | $3.3B |
| Gross Margin | 95.3% | 64.8% | 76.2% | 79.8% | 100.0% |
| R&D Expenses | $711M | $982M | $1.6B | $1.6B | $0 |
| SG&A Expenses | $483M | $707M | $1.1B | $1.3B | $0 |
| Operating Expenses | $1.2B | $1.5B | $2.3B | $2.8B | $2.5B |
| Operating Income | $163M | -$995M | -$1.5B | -$1.5B | $721M |
| Operating Margin | 11.4% | -128.9% | -138.7% | -84.8% | 22.2% |
| Interest Expense | $5M | $7M | $23M | $72M | $0 |
| Income Before Tax | $276M | -$999M | -$1.5B | -$1.5B | $709M |
| Tax Expense | $0 | $0 | $0 | $0 | $749K |
| Net Income | $276M | -$999M | -$1.5B | -$1.5B | $709M |
| Net Margin | 19.4% | -129.4% | -139.5% | -85.5% | 21.8% |
| EPS (Diluted) | $0.57 | $-1.88 | $-2.80 | $-2.73 | $1.29 |
| EBITDA | $188M | -$1.1B | -$1.4B | -$1.2B | $940M |
| Shares Outstanding | 487M | 531M | 540M | 538M | 549M |